Using clinically validated typical ITD mutations in hematologic and non-hematologic diseases that have been mentioned as simulation objects, the above ITD sequences were made into simulation data and used to verify the applicability of the ITDFinder system to ITDs other than FLT3-ITD. The gene discussed is FLT3; the disease is hematologic disorder.